An interventional study of Low Pressure Penumoperitoneum and Standard Pressure Group (No intervention- active comparator) in Surgery, Laparoscopic and Laparoscopy, sponsored by Mount Sinai Hospital, Canada. Recruiting at 1 site in Canada. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-31.
Sponsored by Mount Sinai Hospital, Canada · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 190 studies in Pain, Postoperative with a site in Canada — 38 open to participants now, 42 under way, 3 of them phase 3. Pain, Postoperative · Canada.
Among the 190 studies in Pain, Postoperative with a site in Canada, this one is the 88th largest by planned enrollment of the 175 interventional ones that give a count, is one of 12 that started in 2025, is one of 94 with no phase, reaches primary completion later than 19 of the 41 other live ones, and was the 176th registered.
5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.
Browse Pain, Postoperative studies →38 of the 190 studies in Pain, Postoperative with a site in Canada are open now. Recruiting first, the newest first:
Université de Sherbrooke · Sites in Canada
Ages 18+
Mount Sinai Hospital, Canada · Sites in Canada
Ages 18+ · Women only · Healthy volunteers
Université de Sherbrooke · Sites in Canada
Ages 18+
University of Calgary · Sites in Canada
Ages 18+ · Women only · Healthy volunteers
Unity Health Toronto · Sites in Canada
Ages 18+
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 18 Years and older · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
190 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 8 · Phase 2 17 · Phase 3 22 · Phase 4 38
First in 2004; this study’s year is marked. 12 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 82 is close to the median of 75 across 4,859 interventional studies indexed under Pain, Postoperative.
Median enrollment 82 across the 175 interventional studies, 140 across the 15 observational. Of the 125 that completed or were terminated, 8 (6%) have results posted.
This tab as a report to print or save as PDF → With an account.
9 of 190 have an industry lead sponsor. The 10 most frequent:
Mount Sinai Hospital, Canada is the lead sponsor of 158 studies on the registry; 32 are open to participants now.
Mount Sinai Hospital, Canada has 4 studies filed under Pain, Postoperative — fewer than ten, so there is no comparison to draw.
13 of the studies in Pain, Postoperative with a site in Canada that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07434310Phase 3Dr. Naveed SiddiquiUse of Dexmedetomidine to Improve Pain Control and Recovery After Laparocopic-Assisted Bowel Surgery in Adults | 2027-07-01 |
| NCT06324942University of CalgaryAnalgesic Efficacy of Surgeon-administered Transversus Abdominis Plane Blocks for Caesarean Section. | 2026-12 |
| NCT06276257CHU de Quebec-Universite LavalParavertebral Block for Mastectomy With Immediate Reconstruction | 2026-12 |
| NCT03675386University Health Network, TorontoReducing Opioid Use for Chronic Pain Patients Following Surgery | 2026-12-31 |
| NCT05722002University of MichiganComparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial | 2027-02-10 |
Add all 13 to your calendar (.ics) → With an account.
Among the 190 studies in Pain, Postoperative with a site in Canada, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This proposed study is a single-center, double blind, parallel group RCT comparing the use of low (10 mm Hg) versus standard pressure (15 mm Hg) pneumoperitoneum at the time of benign gynecologic laparoscopic surgery. Patients will be randomized to the control group (standard pressure) or the intervention group (low pressure) and surgeons will be blinded to the study pressure. Data on post-operative recovery and pain scores will be recorded for each patient.
Primary Objective: The primary objective of this study is to determine the effect of low (10 mm Hg) versus standard pressure (15 mm Hg) pneumoperitoneum on post-operative shoulder pain on post operative day one following laparoscopic gynecologic surgery for benign indication.
Secondary Objective: Secondary outcomes measured will include post-operative shoulder tip pain at 1 and 2 hours, QoR score (Appendix A) on POD 1, incidence of post-operative shoulder tip pain (defined as pain rating above zero) at 1, 2, and POD 1, generalized pain, nausea and bloating at 1 and 2 hours and POD 1, as well as rescue analgesia consumption before discharge and use up to POD1. The investigators will also measure intraoperative time, complication rates, estimated blood loss, surgeon visibility rating and anesthetist satisfaction rating, and time to patient discharge. Additionally, investigators will assess rate of failure to complete the surgery at designated pressure (i.e. request to increase pressure).
This proposed study is a single-center parallel group RCT comparing the use of low (10 mm Hg) versus standard pressure (15 mm Hg) pneumoperitoneum at the time of benign gynecologic laparoscopic surgery. Participants will be selected using a convenience sample from Women's College Hospital operating room list. All potentially eligible patients will be invited to participate in this study by the MIS fellow on the day of surgery up to 2 hours before the scheduled surgery. Study consent will be obtained by the MIS fellow or research assistant after the patient has had sufficient time to consider participation in the study.
The investigators will create a randomization list using a computer-generated allocation sequence in equal ratio with study numbers 1 to 82. A member of the research team who will have no interaction with patients in this study will prepare the low and standard pressure envelopes and label them according to the randomization list. Study participants will be randomized on the day of surgery, and the research nurse will set the insufflation pressure to the pre-randomized pressure identified in the envelope. The surgeon, research team, participants and data analysts will be blinded to treatment group. Patients will receive standardized peri-operative care during their operation.
Post-operative pain, nausea, and medication use will be assessed in the PACU. Patients will also be contacted on POD1 to assess post-operative pain scores, calculate total narcotic consumption and elicit any adverse events.
Primary Endpoints: The primary endpoint is post-operative shoulder tip pain measured on POD 1 following surgery by a self-administered NRS for pain. A NRS is a line measuring from 0-10 that rates pain from none (0) to the worst pain imaginable (10). A NRS for subjective pain assessment is a well-established validated measurement tool that has been shown in numerous studies to provide a clinically useful distribution of responses and a detectable treatment effect [Clivatti et al, 2009].
Secondary Endpoints: Secondary outcome measures will include: (a) NRS scores for shoulder-tip pain at 1 and 2 hours (b) QoR score on POD1, (c) NRS scores for generalized pain at 1 and 2 hours and on POD1 (d) post operative nausea, vomiting, and bloating at 1 and 2 hours and on POD1 (e) narcotic consumption measured as total dose of narcotics in PACU and between discharge and the POD1 phone call (f) surgical time (g) estimated blood loss (h) adverse effects/complication rates in hospital and reported by the POD1 phone call (i) surgeon visibility rating and (j) anesthetist satisfaction rating.
Inclusion Criteria: The participant must meet all of the inclusion criteria to eligible for this clinical trial:
Exclusion Criteria: An individual who meets any of the following criteria will be excluded from participation in this clinical trial:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients undergoing laparosocpy at standard pressure (15 mm Hg)
Other: Standard Pressure Group (No intervention- active comparator)
Patients undergoing experimental intervention of low pressure pneumoperitoneum (10 mm Hg)
Procedure: Low Pressure Penumoperitoneum
Maintained Pneumoperitoneum with low pressure of 10 mm Hg
Maintained Pneumoperitoneum at standard pressure of 15 mm Hg
Shoulder Tip Pain
The primary endpoint is post-operative shoulder tip pain measured on post-op day 1 following surgery by a self-administered NRS (numeric rating score) for pain, on a scale from 0 (no pain) to 10 (worst pain imaginable).
Time frame: Post-op day 1
Shoulder Tip Pain (Short-term)
NRS (numeric rating score) scores for shoulder-tip pain at 1 and 2 hours on a scale from 0 (no pain) to 10 (worst pain imaginable)
Time frame: 1 and 2 hours after surgery
Quality of Recovery (QoR) score
QoR (Quality of Recovery) score on post-op day 1: a pre-validated score out of 150 (higher score corresponds to better recovery)
Time frame: Post-op day 1
Generalized Pain Score
Generalized pain at 1 and 2 hours and on post-op day 1. Self-reported NRS pain score on a scale 0-10.
Time frame: 1, 2 hours post-op and post-op day 1
Incidence of Nausea and Vomitting
Documented incidence (yes or no) of nausea, vomiting, and bloating at 1 and 2 hours and on post-op day 1. Incidence/presence of nausea and vomiting is worse.
Time frame: 1, 2 hours post-op and post-op day 1
Narcotic use
Narcotic consumption measured as total dose of narcotics in PACU and between discharge and the post-op day1 phone call
Time frame: Post-op day 1
Surgical time
Duration of surgery
Time frame: Duration of surgery (day surgery)
Estimated blood loss
Estimated blood loss
Time frame: Duration of surgery (day surgery)
Adverse Effect/Complications
Adverse effects/complication rates in hospital and reported by post-op day 1 phone call
Time frame: Post-op day 1
Surgeon visibility
Surgeon visibility rating: visibility during surgery assessed by surgeon rating on a 5-point Likert scale. Greater score indicates better visibility.
Time frame: Duration of surgery
Anesthetist satisfaction
Anesthetist satisfaction rating measured as anesthetist satisfaction with ventilation during surgery. Assessed by anesthetist rating on a 5-point Likert scale (higher score is better).
Time frame: Duration of surgery
Plan to share: Undecided — Undecided
No publications or documents are linked to this record.
Started Jul 2025 (actual). Primary completion is estimated for Jul 2026, 12 months after the start.
Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 12 months is close to that.
Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Mount Sinai Hospital, Canada →